Immix Biopharma, Inc. (IMMX)
NASDAQ·Healthcare·Biotechnology
$8.66
+2.13%
Mkt Cap $459.70M
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (4 analysts)
$14.50
Range $14.00 – $15.00
Implied Upside
+67.4%
Consensus $14.50 vs current $8.66
NASDAQ·Healthcare·Biotechnology
$8.66
+2.13%
Mkt Cap $459.70M
Buy
4
Hold
0
Sell
0
Price Target (4 analysts)
$14.50
Range $14.00 – $15.00
+67.4%
Consensus $14.50 vs current $8.66